loader2
Partner With Us NRI

Company details

29.35
30.40
27.40
65.00
6M Return 4.36%
1Y Return -45.84%
Mkt Cap.(Cr) 229.52
Volume 28,709
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 28,709

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 73.89 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 25,587.81 -37,752.78
LAST 3M 74,012.99 -52,283.98
LAST 6M 141,118.09 -186,787.74
LAST 12M 210,989.03 -181,030.70

Information

  • About Company
  • Company Info
  • Listing Info
3.31
30.76%
14.3105
9.19%
8.14%
Description
  • Ambalal Sarabhai Enterprises Ltd produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. The company operates in two segments, namely pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. Their subsidiaries include Synbiotics Ltd, Haryana Containers Ltd, Asence Inc, Asence Pharma Pvt Ltd, Mautik Exim Ltd, Systronics ( I ) Ltd, Suvik Hitek Pvt Ltd and Vovanties Lab Pvt Ltd. Ambalal Sarabhai Enterprises Ltd was incorporated on June 5, 1978. The company became a public limited company in December 1980. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections. During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99, the company signed agreement with B V Chiron, Netherlands for introducing their anti-cancer drugs in India. During the year 1999-2000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The product division essentially comprising of Sarabai Chemicals products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd. In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd. During the year 2008-09, the Oncology Division launched two new products viz. Fludagem & Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent drug delivery system. During the year 2010-11, the company has transferred and assigned as a going concern the undertaking and business of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and electronics division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010.

Read More

Registered Address

Shanti Sadan, Mirzapur Road, Ahmedabad, Gujarat, 380001

Tel : 91-79-25507671/25507073
Email : ketanadhvaryu:sarabhai.co.in
Website : http://www.ase.life

Registrar

MCS Limited

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500009
NSE Code : AMBASARABH
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE432A01017

ICICIdirect Ambalal Sarabhai Enterprises Ltd FAQ

You can buy Ambalal Sarabhai Enterprises Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Ambalal Sarabhai Enterprises Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 26, 2022 01:00 PM the closing price of Ambalal Sarabhai Enterprises Ltd was ₹ 29.95.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 26, 2022 01:00 PM, the market cap of Ambalal Sarabhai Enterprises Ltd stood at ₹ 229.52.
The latest PE ratio of Ambalal Sarabhai Enterprises Ltd as of May 26, 2022 01:00 PM is 3.31
The latest PB ratio of Ambalal Sarabhai Enterprises Ltd as of May 26, 2022 01:00 PM is 0.47
The 52-week high of Ambalal Sarabhai Enterprises Ltd is ₹ 65.00 while the 52-week low is ₹ 27.40 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE